• Effect
  • In this randomized, controlled trial the researchers assessed whether the addition of raltegravir (a drug that inhibits HIV integrase) to standard ART had any effect on residual viremia. (medindia.net)
  • initial
  • Is it the initial immunincompetence and delayed seroconversion that also keeps viremia low until much later? (thebody.com)